RITTER PHARMACEUTICALS INC Debenture Agreements
3 Contracts & Agreements
- 8% Convertible Debenture dated April 12, 2024, issued by us to Yi Hua Chen (Filed With SEC on April 16, 2024)
- Form of 8% Convertible Debenture to be issued by the Company to Alpha Capital Anstalt [Exhibit A to the Securities Purchase Agreement dated February 26, 2024] (Filed With SEC on February 27, 2024)
- 8% Senior Convertible Debenture Due December 22, 2025 (Filed With SEC on December 22, 2022)
